| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ProQR Therapeutics N.V (NASDAQ: PRQR)
PRQR Technical Analysis
5
| As on 9th Jun 2023 PRQR STOCK Price closed @ 1.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.77 & Strong Sell for SHORT-TERM with Stoploss of 4.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PRQRSTOCK Price
| Open | 1.74 | Change | Price | % |
| High | 1.75 | 1 Day | -0.05 | -2.86 |
| Low | 1.65 | 1 Week | -0.04 | -2.30 |
| Close | 1.70 | 1 Month | -0.48 | -22.02 |
| Volume | 738200 | 1 Year | -6.30 | -78.75 |
| 52 Week High 8.39 | 52 Week Low 0.56 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PRQR Daily Charts |
PRQR Intraday Charts |
Whats New @ Bazaartrend |
PRQR Free Analysis |
|
|
PRQR Important Levels Intraday
| RESISTANCE | 1.89 |
| RESISTANCE | 1.83 |
| RESISTANCE | 1.79 |
| RESISTANCE | 1.75 |
| SUPPORT | 1.65 |
| SUPPORT | 1.61 |
| SUPPORT | 1.57 |
| SUPPORT | 1.51 |
PRQR Forecast May 2024
| 4th UP Forecast | 13.78 |
| 3rd UP Forecast | 9.91 |
| 2nd UP Forecast | 7.51 |
| 1st UP Forecast | 5.12 |
| 1st DOWN Forecast | -1.72 |
| 2nd DOWN Forecast | -4.11 |
| 3rd DOWN Forecast | -6.51 |
| 4th DOWN Forecast | -10.38 |
PRQR Weekly Forecast
| 4th UP Forecast | 3.40 |
| 3rd UP Forecast | 2.85 |
| 2nd UP Forecast | 2.52 |
| 1st UP Forecast | 2.18 |
| 1st DOWN Forecast | 1.22 |
| 2nd DOWN Forecast | 0.88 |
| 3rd DOWN Forecast | 0.55 |
| 4th DOWN Forecast | 0.00 |
PRQR Forecast2024
| 4th UP Forecast | 17.25 |
| 3rd UP Forecast | 12.26 |
| 2nd UP Forecast | 9.18 |
| 1st UP Forecast | 6.1 |
| 1st DOWN Forecast | -2.7 |
| 2nd DOWN Forecast | -5.78 |
| 3rd DOWN Forecast | -8.86 |
| 4th DOWN Forecast | -13.85 |
ProQR Therapeutics N.V ( NASDAQ USA Symbol : PRQR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PRQR Business Profile
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for usher syndrome type 2 and non-syndromic retinitis pigmentosa; QR-1123 that is in phase I/II aurora trial for the treatment of autosomal dominant retinitis pigmentosa; and QR-504a, which is in first clinical trial for the treatment of fuchs endothelial corneal dystrophy. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as ProQR Therapeutics VIII B.V. for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands. Address: Zernikedreef 9, Leiden, Netherlands, 2333 Ck
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service